Medpace Faces Class Action Over Alleged False Statements to Inflate Stock Price
Class action lawsuit filed against $MDPC alleges false statements inflated share price. Investors who bought stock between April 2025 and February 2026 may be eligible.
MEDPsecurities fraudclass action lawsuit